Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcomeAlessandra Iurlo, Pier Mannuccio Mannucci, Fausto Castagnetti et al.|Oncotarget|2016Cited by 35
Iron‐chelating therapy with deferasirox in transfusion‐dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre studyPellegrino Musto, Alessandro Levis, Luca Maurillo et al.|British Journal of Haematology|2017Cited by 25